Search Results - "Carling, Robert W"

Refine Results
  1. 1

    A Second Generation Prostanoid Receptor Antagonist Acting at Multiple Receptor Subtypes by Woodward, David F, Wang, Jenny W, Spada, Clayton S, Carling, Robert W, Martos, Jose L, Pettit, Simon, Kangasmetsa, Jussi, Waterbury, L. David, Lawrence, Matthew, Hu, Wenzheng, Poloso, Neil J

    Published in ACS pharmacology & translational science (11-12-2020)
    “…It has previously been reported that a prototypical compound (AGN 211377), which blocks pro-inflammatory prostanoid receptors (DP1, DP2, EP1, EP4, FP, TP) and…”
    Get full text
    Journal Article
  2. 2

    In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti‐inflammatory effects by Woodward, David F., Wang, Jenny W., Ni, Ming, Bauer, Alex, Martos, Jose L., Carling, Robert W., Poloso, Neil J.

    Published in The FASEB journal (01-01-2017)
    “…The purpose of these studies was to test the hypothesis that a selected polypharmacological approach for treating the prostanoid‐mediated component of…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Multitargeting of selected prostanoid receptors provides agents with enhanced anti‐inflammatory activity in macrophages by Wang, Jenny W., Woodward, David F., Martos, Jose L., Cornell, Clive L., Carling, Robert W., Kingsley, Philip J., Marnett, Lawrence J.

    Published in The FASEB journal (01-01-2016)
    “…ABSTRACT A polypharmacologic approach to prostanoid based anti‐inflammatory therapeutics was undertaken in order to exploit both the anti‐ and proinflammatory…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Cellular basis for bimatoprost effects on human conventional outflow by Stamer, W Daniel, Piwnica, David, Jolas, Thierry, Carling, Robert W, Cornell, Clive L, Fliri, Hans, Martos, Jose, Pettit, Simon N, Wang, Jenny W, Woodward, David F

    “…Bimatoprost is a widely used ocular hypotensive agent to treat glaucoma. It lowers intraocular pressure in humans by increasing both pressure-independent…”
    Get full text
    Journal Article
  7. 7

    4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor by Leeson, Paul D, Carling, Robert W, Moore, Kevin W, Moseley, Angela M, Smith, Julian D, Stevenson, Graeme, Chan, Tony, Baker, Raymond, Foster, Alan C

    Published in Journal of medicinal chemistry (01-05-1992)
    “…trans-2-Carboxy-5,7-dichloro-4-amidotetrahydroquinolines, evolved from the lead 5,7-dichlorokynurenic acid, have been synthesized and tested for in vitro…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: Functionally selective GABAA α3-subtype agonists by Carling, Robert W., Russell, Michael G.N., Moore, Kevin W., Mitchinson, Andrew, Guiblin, Alexander, Smith, Alison, Wafford, Keith A., Marshall, George, Atack, John R., Street, Leslie J.

    Published in Bioorganic & medicinal chemistry letters (01-07-2006)
    “…Novel synthetic routes have been devised for the preparation of previously inaccessible 2,3,7-trisubstituted pyrazolo[1,5-d][1,2,4]triazines 2. These compounds…”
    Get full text
    Journal Article
  20. 20